![James Parsons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Parsons
Président chez
DIAMEDICA THERAPEUTICS INC.
Fortune : 577 743 $ au 31/05/2026
Profil
Mr. James T.
Parsons, CPA, is a Chief Financial Officer & Director at Sernova Biotherapeutics, Inc. and a Chairman at DiaMedica Therapeutics, Inc. He is on the Board of Directors at Oncolytics Biotech, Inc. and Sernova Biotherapeutics, Inc. Mr. Parsons was previously employed as a Chief Financial & Accounting Officer by Trillium Therapeutics, Inc., a Chief Financial Officer by Amorfix Life Sciences Ltd., a Chief Financial Officer & Secretary by Trillium Therapeutics, Inc. /Old/, a Vice President-Finance & Administration by Lorus Therapeutics, Inc., and a Controller & Assistant Treasurer by Timminco Ltd. He also served on the board at YM BioSciences, Inc. He received his graduate degree from The University of Waterloo.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 75 854 ( -.--% ) | 454 365 $ | 31/05/2026 | |
| 14/04/2026 | 614 605 ( 0,18 % ) | 66 377 $ | 31/05/2026 | |
ONCOLYTICS BIOTECH INC. 0,04 % | 01/06/2026 | 41 849 ( 0,04 % ) | 43 523 $ | 31/05/2026 |
| 01/06/2026 | 2 250 ( 0 % ) | 13 478 $ | 31/05/2026 |
Postes actifs de James Parsons
| Sociétés | Poste | Début |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Président | 01/01/2025 |
| SERNOVA BIOTHERAPEUTICS INC | Directeur Financier/CFO | 11/10/2024 |
| ONCOLYTICS BIOTECH INC. | Directeur/Membre du Conseil | 16/06/2022 |
Anciens postes connus de James Parsons
| Sociétés | Poste | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | Directeur Financier/CFO | 17/11/2021 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Directeur Financier/CFO | 06/06/2014 |
| PROMIS NEUROSCIENCES, INC. | Directeur Financier/CFO | 20/10/2010 |
| APTOSE BIOSCIENCES INC. | Directeur Financier/CFO | 01/01/2003 |
| TIMMINCO LIMITED | Comptroller/Controller/Auditor | 01/01/2000 |
Formation de James Parsons
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Produces cancer-related drug products | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Timminco Ltd.
 Timminco Ltd. Metal FabricationProducer Manufacturing Manufactures specialty magnesium, calcium and strontium alloys | Producer Manufacturing |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
